5.4 Mechanical Circulatory Support & Post-Cardiac Arrest Care

5.4 Mechanical Circulatory Support & Post-Cardiac Arrest Care

Mechanical Circulatory Support (MCS) devices and advanced post-cardiac arrest neuroprotective bundles represent the pinnacle of critical care cardiac transport. Managing patients supported by Intra-Aortic Balloon Pumps (IABP), Ventricular Assist Devices (VADs), or Extracorporeal Membrane Oxygenation (ECMO) requires specialized knowledge of device physics, alarm troubleshooting, transport kinetics, and strict physiological targets.

---

Intra-Aortic Balloon Pump (IABP) Counterpulsation

The Intra-Aortic Balloon Pump is a temporary mechanical circulatory assist device designed to reduce left ventricular workload and improve myocardial oxygen supply-demand dynamics.

Balloon Physics & Anatomical Position

• Gas Selection: The balloon is inflated with Helium gas. Helium is selected because of its exceptionally low density (allowing rapid transport through shuttle tubing during high cardiac cycles) and high solubility in blood (reducing gas embolism risks in the event of balloon rupture).
• Catheter Placement: Inserted percutaneously via the femoral artery into the descending thoracic aorta. The balloon tip must sit 1 to 2 cm distal to the origin of the left subclavian artery and proximal to the renal artery origins (verified radiographically at the 2nd to 3rd intercostal space level).

+--------------------------------------------------------------------------+
|                       IABP TIMING & PHYSIOLOGY                           |
|                                                                          |
|  1. INFLATION  --->  At Dicrotic Notch (Aortic Valve Closure / Diastole) |
|                      Result: DIASTOLIC AUGMENTATION                      |
|                      Benefit: Marked Increase in Coronary Perfusion       |
|                                                                          |
|  2. DEFLATION  --->  Immediately Before Systole (R-Wave on ECG)          |
|                      Result: VACUUM EFFECT / AFTERLOAD REDUCTION         |
|                      Benefit: Decreases LV Workload & MVO2 by 20%        |
+--------------------------------------------------------------------------+

Inflation & Deflation Physiology

1. Inflation at Diastole: The balloon inflates precisely at the dicrotic notch on the arterial pressure waveform, marking aortic valve closure and the onset of diastole. Inflation pushes blood retrograde toward the aortic root (Diastolic Augmentation), dramatically increasing coronary artery blood flow and oxygen supply.
2. Deflation at Systole: The balloon deflates rapidly immediately prior to isometric ventricular contraction (aligned with the R-wave on ECG, just before the aortic valve opens). Rapid deflation creates a transient vacuum (Venturi effect) in the descending aorta, decreasing aortic end-diastolic pressure. This reduces Left Ventricular Afterload and myocardial oxygen consumption ($MVO_2$) by up to 20-30%, while augmenting cardiac output by 15-20%.

IABP Timing Errors & Waveform Analysis

Proper IABP operation requires synchronized ECG (R-wave) or arterial line pressure wave triggering.

TIMING ERRORS & WAVEFORM PATTERNS:

Early Inflation: Inflation BEFORE dicrotic notch
  - Closes aortic valve prematurely -> Severe LV strain & Aortic Regurgitation

Late Inflation: Inflation AFTER dicrotic notch
  - Suboptimal diastolic peak -> Loss of coronary perfusion benefit

Early Deflation: Deflation early in diastole
  - Sharp drop in diastolic trace -> Loss of afterload reduction

Late Deflation: Deflation AFTER systole initiates
  - LV ejects against inflated balloon -> Catastrophic increase in LV Afterload & MVO2

• Early Inflation: Inflation occurs before aortic valve closure. Result: Premature aortic valve closure, increased LV end-systolic volume, increased afterload, and potential aortic regurgitation.
• Late Inflation: Inflation occurs well after the dicrotic notch. Result: Subtherapeutic diastolic augmentation and suboptimal coronary artery perfusion.
• Early Deflation: Deflation occurs prematurely during mid-diastole. Result: Loss of diastolic augmentation and lack of afterload reduction.
• Late Deflation: Deflation occurs after ventricular ejection has begun (LV pumps directly against an inflated balloon). Result: Severe increase in LV afterload, massive spike in $MVO_2$, reduced cardiac output, and cardiac decompensation.

Critical Care Transport Considerations

• Altitude Changes: Changes in barometric pressure during rotor/fixed-wing flight affect helium volume (Boyle's Law). Modern IABP consoles automatically perform automatic helium purges during climb/descent.
• Balloon Rupture Detection: Inspect the clear shuttle line for the presence of flakes of blood or liquid blood. If blood is visualized in the tubing, immediately stop the pump console, clamp the balloon line to prevent gas embolism, notify the receiving surgical team, and prepare for manual inflation protocols if indicated.

---

Ventricular Assist Devices (VADs)

Ventricular Assist Devices (such as the HeartMate II, HeartMate 3, and HVAD) are implantable mechanical pumps that withdraw blood from the left ventricular apex and eject it continuously into the ascending aorta.

Continuous-Flow Mechanics & Physiological Signatures

• Non-Pulsatile Circulation: Modern VADs utilize continuous-flow centrifugal or axial impellers spinning at 2,000 to 10,000 RPM. As a result, patients typically have no palpable pulse, a narrow or absent pulse pressure, and non-measurable oscillometric non-invasive blood pressures (NIBP).
• Measuring Blood Pressure: Standard automated NIBP cuffs fail to register accurate readings. Mean Arterial Pressure (MAP) MUST be measured using a Doppler ultrasound probe placed over the brachial or radial artery while deflating a manual blood pressure cuff. The pressure at which the first continuous flow whistle sound returns represents the MAP.
  • Target MAP: Maintain strict MAP between 65 and 80 mmHg. MAP $> 85-90\text{ mmHg}$ increases pump afterload, reduces VAD flow, and increases stroke/bleeding risks.

Controller Alarms & Troubleshooting

CPR & Resuscitation Precautions

• Chest Compressions: Manual chest compressions carry risk of cannula dislodgement or ventricular tearing. If a VAD patient is unresponsive:
  1. Auscultate the left chest for the continuous mechanical hum of the VAD pump.
  2. Check all driveline connections, controller status, and battery power sources.
  3. Obtain Doppler MAP. If MAP $< 50\text{ mmHg}$ or absent with no pump hum, follow regional/institutional protocol regarding chest compressions while addressing reversible causes (hypovolemia, dysrhythmias).

---

Extracorporeal Membrane Oxygenation (ECMO) Basics

ECMO provides temporary extracorporeal cardiopulmonary support for patients with severe refractory respiratory or cardiac failure.

VA-ECMO (Veno-Arterial): Drains Vein ---> Oxygenates ---> Pumps to ARTERY
  - Supports: BOTH Heart & Lungs (Cardiac + Respiratory Failure)
  - Risk: Harlequin Syndrome (North-South Syndrome) - Upper body hypoxia

VV-ECMO (Veno-Venous):  Drains Vein ---> Oxygenates ---> Returns to VEIN
  - Supports: Lungs ONLY (Isolated Respiratory Failure)
  - Requires: Intact Native Cardiac Pump Function

1. Veno-Arterial (VA) ECMO: Blood is drained from a central vein (e.g., femoral vein or RA), passed through a membrane oxygenator/heat exchanger, and pumped under pressure into a major systemic artery (e.g., femoral artery or aorta). VA-ECMO provides full cardiac and pulmonary support.
   • Harlequin / North-South Syndrome: In femoral VA-ECMO, if native left ventricular cardiac function recovers while pulmonary function remains severely impaired, the native heart ejects deoxygenated blood into the ascending aorta while the ECMO circuit delivers oxygenated blood retrograde up the descending aorta. This results in upper body (brain, right arm) hypoxia alongside lower body normoxia. Monitor $\text{SpO}_2$ on the right hand to detect Harlequin syndrome.
2. Veno-Venous (VV) ECMO: Blood is drained from the venous system and returned to the venous system (e.g., right atrium). VV-ECMO provides pulmonary gas exchange only ($\text{O}_2$ delivery and $\text{CO}_2$ removal) and requires adequate native cardiac output.

---

Post-Cardiac Arrest Care & Targeted Temperature Management (TTM)

Following Return of Spontaneous Circulation (ROSC), patients suffer from post-cardiac arrest syndrome, characterized by brain injury, myocardial dysfunction, and systemic ischemia-reperfusion response.

Targeted Temperature Management (TTM) Protocols

• Target Core Temperature: Maintain strict, constant core temperature between 32°C and 36°C (or strict normothermia 36°C - 37.5°C) for at least 24 hours post-ROSC.
• Neuroprotective Mechanisms: TTM reduces Cerebral Metabolic Rate for Oxygen ($CMRO_2$) by 6-8% for every 1°C decrease in body temperature. It suppresses free radical production, inhibits apoptosis, reduces blood-brain barrier permeability, and minimizes cerebral edema.
• Shivering Suppression: Shivering increases metabolic heat production and oxygen consumption by up to 200%. Manage shivering using stepwise interventions: magnesium sulfate infusions, counter-warming skin wraps, sedation (Propofol, Fentanyl), and continuous neuromuscular blockade (Rocuronium/Vecuronium).
• Re-warming Phase: Re-warm slowly at a rate of 0.25°C to 0.5°C per hour. Rapid re-warming causes severe hyperkalemia, peripheral vasodilation, and refractory hypotension.

Post-ROSC Oxygenation & Ventilation Targets

• Avoid Hyperoxia: Target $\text{SpO}_2$ 92 - 98% (or $\text{PaO}_2\text{ 80 - 100 mmHg}$). Hyperoxia (defined as $\text{PaO}_2 > 300\text{ mmHg}$) generates massive reactive oxygen species (ROS), causing intense cerebral vasoconstriction and worsening reperfusion brain injury.
• Avoid Hypocapnia: Target strict normocapnia ($\text{PaCO}_2\text{ 35 - 45 mmHg}$). Carbon dioxide is a potent cerebral vasodilator:
  • Hypocapnia ($\text{PaCO}_2 < 35\text{ mmHg}$) causes profound cerebral vasoconstriction, dangerously reducing cerebral blood flow and inducing ischemic brain injury.
  • Severe Hypercapnia ($\text{PaCO}_2 > 50\text{ mmHg}$) causes cerebral vasodilation, increasing intracranial pressure (ICP).